| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | RVI BIOTECNOLOGÍA | 55,27% | 57,31% | 33,12% | 116,69% |
| BGF EMERGING MARKETS EQUITY INCOME A8 AUD (HEDGED) | RVI EMERGENTES | 55,26% | 67,53% | 22,02% | · |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS Y-ACC-USD | RVI ASIA EX-JAPÓN SMALL/MID CAP | 55,23% | 91,45% | 55,44% | 155,21% |
| MAPFRE AM - GOOD GOVERNANCE FUND I EUR CAP | RVI GLOBAL | 55,22% | 70,42% | 57,35% | · |
| GOLDMAN SACHS GLOBAL FUTURE TECHNOLOGY LEADERS EQUITY PORTFOLIO BASE USD DIS | RVI TECNOLOGÍA | 55,19% | 105,84% | 38,72% | · |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 55,18% | 104,73% | 94,45% | 374,93% |
| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS EX CHINA N EUR CAP | RVI EMERGENTES | 55,18% | · | · | · |
| ABRDN SICAV I-EMERGING MARKETS EX CHINA EQUITY FUND I ACC USD | RVI EMERGENTES | 55,16% | 83,69% | 44,82% | · |
| GOLDMAN SACHS GLOBAL FUTURE TECHNOLOGY LEADERS EQUITY PORTFOLIO BASE USD CAP | RVI TECNOLOGÍA | 55,16% | 105,68% | 38,62% | · |
| RENTA 4 MEGATENDENCIAS / ARIEMA HIDROGENO | RVI ENERGÍA | 55,15% | 23,11% | -18,71% | · |
